These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 6138599)
1. Unique pattern of Epstein-Barr virus specific antibodies in recurrent parotitis. Akaboshi I; Katsuki T; Jamamoto J; Matsuda I Lancet; 1983 Nov; 2(8358):1049-51. PubMed ID: 6138599 [TBL] [Abstract][Full Text] [Related]
2. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
3. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. Linde A; Andersson J; Lundgren G; Wahren B J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoprecipitation in the diagnosis of chronic active Epstein-Barr virus infection. Beauparlant P; Alfieri C; Joncas JH J Med Virol; 1994 Mar; 42(3):241-6. PubMed ID: 8006636 [TBL] [Abstract][Full Text] [Related]
5. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins. Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups. Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990 [TBL] [Abstract][Full Text] [Related]
7. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
8. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections. Cevenini R; Donati M; Rumpianesi F; Moroni A; Paolucci P J Clin Pathol; 1984 Apr; 37(4):440-3. PubMed ID: 6323549 [TBL] [Abstract][Full Text] [Related]
10. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. van Grunsven WM; Spaan WJ; Middeldorp JM J Infect Dis; 1994 Jul; 170(1):13-9. PubMed ID: 8014488 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma]. Mendoza J; Rojas A; de la Rosa M; Amador JM; Expósito J; Esquivias J Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma. Kaschka WP; Hilgers R; Skvaril F Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114 [TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
14. Benign and malignant disease caused by EBV. Wolf H; Seibl R J Invest Dermatol; 1984 Jul; 83(1 Suppl):88s-95s. PubMed ID: 6330230 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay of antibodies to Epstein-Barr virus nuclear and early antigens in patients with infectious mononucleosis and nasopharyngeal carcinoma. Halprin J; Scott AL; Jacobson L; Levine PH; Ho JH; Niederman JC; Hayward SD; Milman G Ann Intern Med; 1986 Mar; 104(3):331-7. PubMed ID: 3004279 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children. Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Nystad TW; Myrmel H J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144 [TBL] [Abstract][Full Text] [Related]
18. Contribution to rapid diagnosis of infectious mononucleosis. Franková V; Stanková M; Kouba K; Hásková V; Pavlík E Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease. Bardy B; Morinet F; Pérol Y Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178 [TBL] [Abstract][Full Text] [Related]